Serum cfDNA TP53 variants were analyzed in 42 ESCC and compared to matched tumor DNA variants previously identified by Sanger sequencing, providing a concordance ratio between cfDNA and tumor DNA. The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.